FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss – FDA.gov
|
FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
FDA.gov “Today’s approval marks another first in the field of gene therapy — both in how the therapy works and in expanding the use of gene therapy beyond the treatment of cancer to the treatment of vision loss — and this milestone reinforces the potential … |
FDA.gov |
What Is Gene Therapy? How Does It Work?
FDA.gov Gene therapy can be used to modify cells inside or outside the body. When it’s done inside the body, a doctor will inject the vector carrying the gene directly into the part of the body that has defective cells. In gene therapy that is used to modify … |
Muscular Dystrophy News |
Gene Therapy Approach Using HAC Vector May Work with Dystrophin Gene, Study Suggests
Muscular Dystrophy News Gene therapy aims to treat DMD, caused by mutations in the dystrophin gene, by delivering the correct version of the gene to patients’ cells to replace the faulty version. But the considerable size of the dystrophin gene makes it difficult for … |
|
Singapore’s IP Office to Grant Merck’s Patent Application for CRISPR Technology
AsiaOne This forthcoming, fundamental patent in Singapore, entitled “CRISPR-BASED GENOME MODIFICATION AND REGULATION,” covers chromosomal integration, or cutting of the chromosomal sequence of eukaryotic cells (such as mammalian and plant cells) and insertion … Singapore’s IP Office to Grant MilliporeSigma’s Patent Application for …PR Newswire (press release) |
|
Singapore’s IP Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology
Canada NewsWire (press release) “Singapore’s notice of patent allowance for MilliporeSigma’s CRISPR integration technology is yet another reinforcement of our intellectual property,” said Udit Batra, CEO, MilliporeSigma. “We look forward to receiving additional grants for similar … |